Clinical Trial

Asymptomatic TB With Innovative Modified Short-course Regimens

Study acronym: SWIFT
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study is a randomized controlled trial among asymptomatic tuberculosis individuals aiming to assess whether the standard treatment duration can be shortened to 17 weeks without increasing the types or doses of anti-tuberculosis medications or 13 weeks with the high-dose rifapentine and moxifloxacin.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-11-22; most recent amendment 2026-02-08.
Status change: Active, Not Recruiting → Recruiting 2026-02-08
Trial Details
NCT Number NCT06153069
Lead Sponsor Huashan Hospital
Collaborators: University of Toronto
Conditions Tuberculosis
Enrollment 426 participants
Start Date 2025-11-21
Primary Completion 2027-11 (estimated)
Study Completion 2028-11 (estimated)
Updated on ClinicalTrials.gov 2026-02-11